Group urges Congress to create ‘overdue’ definition of LTC pharmacy
Published by McKnight’s
Differing definitions of long-term care pharmacies used by government agencies may threaten seniors’ care and disrupt care coordination, according to a leading long-term care pharmacy group.
In a policy brief released Monday, the Senior Care Pharmacy Coalition urged Congress and other regulatory authorities to adopt a “statutory, legislative” definition of long-term care pharmacies in order to ensure consistency across care settings for the more than 1.4 million Americans receiving the pharmacies’ services.
Currently the Centers for Medicare & Medicaid Services uses the “most comprehensive” definition of long-term care pharmacy, while the definitions used by the Environmental Protection Agency and the Food and Drug Administration are “far less concise,” SCPC said.
The policy brief also encourages Congress to address the “rapidly diversifying LTC marketplace,” and how LTC pharmacies should “operate in a future driven by diverse value-based purchasing models of [healthcare] delivery.”
SCPC will follow up the policy brief later this year with a potential definition of long-term care pharmacy for regulators to consider, said Alan Rosenbloom, president and CEO of SCPC.
“The range of activist federal agencies seeking to regulate LTC pharmacies today demands that Congress adopt a clear, statutory definition that explicitly identifies the unique and specific service offerings that LTC pharmacies provide,” Rosenbloom said. “Only by doing so can federal laws appropriately — and consistently — apply to the practice of LTC pharmacy, particularly in the face of a growing need for LTC services in our rapidly evolving [healthcare] delivery system.”
Click here to see the original article on the McKnight’s website.
Recent Posts
-
SCPC Releases Statement in Support of Government Accountability Office (GAO) Report on the Inflation Reduction Act
SCPC has repeatedly warned about the impact of the Inflation Reduction Act’s (IRA) mandatory Medicare drug price negotiations on LTC pharmacies and the millions of vulnerable seniors they serve. We are glad the Government Accountability Office (GAO) is examining how these policies are affecting pharmacies, particularly LTC pharmacies, which already operate under a broken reimbursement model that often requires them to dispense many of the most commonly used medications at a loss.
-
SCPC Applauds President Trump’s Executive Order Calling on HHS and Congress to Improve the IRA, Rein In PBMs and Lower Drug Costs
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care (LTC) pharmacy community, released the following statement applauding President Trump’s recent Executive Order aimed at improving the Inflation Reduction Act (IRA), lowering drug prices and addressing the harmful actions of PBMs. “For far too long, pharmacy benefit managers (PBMs) have taken […]
-
60 percent of LTC pharmacies warn of closure amid major drug pricing changes
Facing deep losses on high-demand medications, 85% of long-term care pharmacies say they will limit essential services and 60% will close locations without changes to Medicare drug pricing efforts. Those are among the “unintended consequences” revealed in a Senior Care Pharmacy Coalition survey released Wednesday. The trade association has been increasingly vocal about pricing changes set to go into effect in January.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.